Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Daiichi Sankyo Opens New Toronto HQ | Contract Pharma

What are you searching for?

Sign in
Breaking News

Daiichi Sankyo Opens New Toronto HQ

Aims to accelerate investment and innovation in oncology in Canada.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma
Daiichi-Sankyo

Daiichi Sanyko executives attended the Canadian headquarters grand opening.

Daiichi Sankyo has expanded its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and R&D investments to advance its efforts in oncology.

“Establishing a permanent headquarters in Toronto represents a significant milestone in our global expansion and reflects the strong commitment of Daiichi Sankyo to patients and partners in Canada,” said Masahiro Kato, Managing Director, Europe and Canada, Daiichi Sankyo. “Canada is home to a vibrant healthcare and life sciences ecosystem where we see immense potential for continued growth through scientific innovation and collaboration, solidifying Canada’s role as a global contributor to improve standards of care.”

Over the past two years, Daiichi Sankyo has supported 18 oncology clinical trials across 43 sites in Canada, working with cancer centers such as Princess Margaret Cancer Centre, CHUM, BC Cancer, McGill University Health Centre and The Ottawa Hospital.

Related News: Daiichi Plans to Invest $1.9B in Production Facilities

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics